Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Jan / Novel OCT Metric
Research & Innovations Glaucoma

Novel OCT Metric

TVST study introduces a novel OCT metric that outperforms other OCT metrics in detecting glaucomatous damage

By The Ophthalmologist 1/14/2025 1 min read

Share

Credit: Shutterstock.com

A recent study undertaken by researchers at Columbia University Irving Medical Center has introduced a new pattern-based optical coherence tomography (OCT) metric for detecting glaucomatous damage. Developed using a logistic regression modeling (LRM) model, the novel metric leverages six variables derived from characteristic patterns of glaucomatous loss observed in OCT scans of the ganglion cell layer plus inner plexiform layer (GCL+IPL) and retinal nerve fiber layer (RNFL).

The research team, led by Donald C. Hood and colleagues, analyzed OCT data from multiple cohorts, including 400 healthy individuals and 207 with OCT-detected glaucomatous optic neuropathy (ON-G). Sensitivity and specificity were evaluated using additional test sets, ensuring a wide range of glaucomatous damage levels. Results showed that the new metric achieved a partial area under the ROC curve (AUROC) of 0.92 and a sensitivity of 88.8 percent at 95 percent specificity – significantly outperforming previous OCT metrics, such as global RNFL thickness (57.5 percent sensitivity) and global GCL+IPL thickness (47.6 percent sensitivity).

The authors believe this new metric could be particularly useful for detecting subtle patterns of glaucomatous damage that are often missed by other conventional OCT measurements. By accounting for regional vulnerabilities, such as superior and inferior arcuate thinning, the novel approach demonstrates higher accuracy for both clinical practice and glaucoma screening programs.

The authors emphasize that the new OCT metric could improve glaucoma risk assessments, aid primary care referrals to specialists, and serve as a reliable endpoint for clinical trials. They also highlight its potential role in refining OCT reports to better support clinical decision-making, bridging the gap between automated and subjective interpretations of glaucomatous damage.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: